Assessing cytotoxicity of (iron oxide-based) nanoparticles: An overview of different methods exemplified with cationic magnetoliposomes

Contrast Media and Molecular Imaging

Volumn 4, Issue 5, 2009, Pages 207-219

  Soenen, Stefaan J H ^a   De Cuyper, Marcel ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cell physiology; Cellular proliferation; Cellular uptake; Cellular viability; Cytotoxicity; Iron oxide nanoparticles; Magnetoliposomes; MRI contrast agent

Indexed keywords

ACTIN; CATION; LIPID; LIPOSOME; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; REACTIVE OXYGEN METABOLITE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

CELL ASSAY; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL LABELING; CELL LEVEL; CELL PROLIFERATION; CELL TRANSPORT; CELL VIABILITY; CONCENTRATION (PARAMETERS); CYTOARCHITECTURE; CYTOSKELETON; CYTOTOXICITY; FOCAL ADHESION; INTERMETHOD COMPARISON; INTERNALIZATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; STEM CELL; TOXICITY TESTING;

ANIMALS; CATIONS; CELL DEATH; FERRIC COMPOUNDS; HUMANS; LIPOSOMES; MAGNETICS; NANOPARTICLES;

EID: 71649084288     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.282     Document Type: Review

References (63)

1. Bulte JW, Zhang S, van Gelderen P, Herynek V, Jordan EK, Duncan ID, Frank JA. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl Acad. Sci. USA 1999; 96: 15256-15261.
2. Walczak P, Kedziorek DA, Gilad AA, Barnett BP, Bulte JW. Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn. Reson. Med. 2007; 58: 261-269.
3. Boutry S, Brunin S, Mahieu I, Laurent S, Vander Elst L, Muller RN. Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study. Contrast Media Mol. Imag. 2008; 3: 223-232.
4. Küstermann E, Himmelreich U, Kandal K, Geelen T, Ketkar A, Wiedermann D, Strecker C, Esser J, Arnhold S, Hoehn M. Efficient stem cell labeling for MRI studies. Contrast Media Mol. Imag. 2008; 3: 27-37.
5. Geraldes CF, Laurent S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol. Imag. 2009; 4: 1-23.
6. Wilhelm C, Gazeau F. Universal cell labeling with anionic magnetic nanoparticles. Biomaterials 2008; 29: 3161-3174.
7. Amstad E, Zurcher S, Mashagi A, Wong YJ, Textor M, Reimhult E. Universal cell labelling with anionic magnetic nanoparticles. Small 2009; 5: 1334-1342.
8. Idee JM, Port M, Raynal I, Schaefer M, Bonnemain B, Prigent P, Robert P, Robic C, Corot C. Superparamagnetic nanoparticles of iron oxides for magnetic resonance imaging applications. In Nanotechnologies for the Life Sciences, Kumar C (ed). Wiley- VCH: Weinheim, 2007; 51-84.
9. Soenen SJ, Hodenius M, De Cuyper M. Magnetoliposomes: versatile innovative nanocolloids for use in biotechnology and biomedicine. Nanomedicine 2009; 4: 177-191.
10. Arbab AS, Wilson LB, Ashari B, Jordan EK, Lewis BK, Frank JA. A model of lysosomal metabolism of dextran coated superpara-magnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed. 2005; 18: 383-389.
11. Stroh A, Zimmer C, Gutzeit C, Jakstadt M, Marschinke F, Jung T, Pilgrimm H, Grune T. Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic. Biol. Med. 2004; 36: 976-984.
12. Shapiro EM, Medford-Davis LN, Fahmy TM, Dunbar CE, Koretsky AP. Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI. Contrast Media Mol. Imag. 2007; 2: 147-153.
13. Bulte JW, Couglas T, Witwer B, Zhang S-C, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan IA, Frank JA. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 2001; 19: 1141-1147.
14. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003; 24: 1001-1011. (Pubitemid 36024170)
15. De Cuyper M, Joniau M. Magnetoliposomes: formation and structural characterization. Eur. Biophys. J. 1998; 15: 311-319.
16. Bhogal N. Regulatory and scientific barriers to the safety evaluation of medical nanotechnologies. Nanomedicine 2009; 4: 495-498.
17. Sun C, Sze R, Zhang M. Folic acid-PEG conjugated super-paramagnetic nanoparticles for targeted cellular uptake and detection by MRI. J. Biomed. Mater. Res. A 2006; 78: 550-557.
18. Huang G, Diakur J, Xu Z, Wiebe LI. Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. Int. J. Pharm. 2008; 360: 197-203.
19. Sun C, Fang C, Stephen Z, Veiseh O, Hansen S, Lee D, Ellenbogen RG, Olson J, Zhang M. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. Nanomedicine 2008; 3: 495-505.
20. Santra S, Kaittanis C, Grimm J, Perez JM. Drug/Dye-Loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. Small 2009; DOI: 10.1002/smll.200900389.
21. Shi D, Cho HS, Chen Y, Xu H, Gu H, Lian J, Wang W, Liu G, Huth C, Wang L, Ewing RC, Budko S, Pauletti G, Dong Z. Fluorescent polystyrene-Fe3O4 composite nanospheres for in vivo imaging and hyperthermia. Adv. Mater. 2009; 21: 2170-2173.
22. Kaiser JP, Krug HF, Wick P. Nanomaterial cell interactions: how do carbon nanotubes affect cell physiology? Nanomedicine 2009; 4: 57-63.
23. Lohrke J, Briel A, Mäder K. Characterization of superparamagnetic iron oxide nanoparticles by asymmetrical flow-field-flow-fractionation. Nanomedicine 2008; 3: 437-452.
24. Díaz B, Sánchez-Espinel C, Arruebo M, Faro J, de Miguel E, Magadán S, Yagüe C, Fernández-Pacheco R, Ibarra MR, Santamaría J, González-Fernández A. Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. Small 2008; 4: 2025-2034.
25. Li P, Li D, Zhang L, Li G, Wang E. Cationic lipid bilayer coated gold nanoparticles-mediated transfection of mammalian cells. Biomaterials 2008; 29: 3617-3624.
26. Soenen SJ, Baert J, De Cuyper M. Optimal conditions for labelling of 3T3 fibroblasts with magnetoliposomes without affecting cellular viability. Chembiochem 2007; 8: 2067-2077. (Pubitemid 350220757)
27. Soenen SJ, Brisson A, De Cuyper M. Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials 2009; 30: 3691-3701.
28. Soenen SJ, Vercauteren D, Braeckmans K, Noppe W, De Smedt S, De Cuyper M. Stable long-term intracellular labelling with fluorescently tagged cationic magnetoliposomes. Chembiochem 2009; 10: 257-267.
29. Schäfer R, Kehlbach R, Wiskirchen J, Bantleon R, Pintaske J, Brehm BR, Gerber A, Wolburg H, Claussen CD, Northoff H. Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. Radiology 2007; 244: 514-523. (Pubitemid 47080884)
30. Mailänder V, Lorenz MR, Holzapfel V, Musyanovych A, Fuchs K, Wiesneth M, Walther P, Landfester K, Schrezenmeier H. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol. Imag. Biol. 2008; 10: 138-146.
31. Wang L, Wang Z, Frank TG, Brown SI, Chudek SA, Cuschieri A. Rapid and efficient cell labeling with a MRI contrast agent by electroporation in the presence of protamine sulfate. Nanomedicine 2009; 4: 305-315.
32. Monteiro-Riviere NA, Inman AO, Zhang LW. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 2009; 234: 222-235.
33. Hoshino A, Fujioka K, Oku T, Suga M, Sasaki YF, Ohta T, Yasuhara M, Suzuki K, Yamamoto K. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett. 2004; 4: 2163-2169.
34. Huang LC, Wu JH. Cell density-dependent proliferation of the murine bone marrow-derived stromal cell lines. Biotechnol. Lett. 1997; 19: 89-92.
35. Bulte JW, Arbab T, Douglas T, Frank J. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Meth. Enzymol. 2004; 386: 275-299.
36. Foucaud L, Wilson MR, Brown DM, Stone V. Measurement of reactive species production by nanoparticles prepared in biologically relevant media. Toxicol. Lett. 2007; 174: 1-9.
37. Tang M,Wang M, Xing T, Zeng J,Wang H, Ruan DY. Mechanisms of unmodified CdSe quantum dot-induced elevation of cytoplasmic calcium levels in primary cultures of rat hippocampal neurons. Biomaterials 2008; 33: 4383-4391.
38. Tirlapur UK, König K, Peuckert C, Krieg R, Halbhuber KJ. Femto-second near-infrared laser pulses elicit generation of reactive oxygen species in mammalian cells leading to apoptosis-like death. Exp. Cell Res. 2001; 263: 88-97.
39. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 2009; 8: 579-591.
40. Neyens E, Baeyens J. A review of classic Fenton's peroxidation as an advanced oxidation technique. J. Hazard. Mater. 2003; 98: 33-50.
41. Takano S, Aramaki Y, Tsuchiya S. Lipoxygenase may be involved in cationic liposome-induced macrophage apoptosis. Biochem. Biophys. Res. Commun. 2001; 288: 116-120.
42. Gao L, Zhuang J, Nie L, Zhang J, Zhang Y, Gu N, Wang T, Feng J, Yang D, Perrett S, Yan X. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nat. Nanotechnol. 2007; 2: 577-583.
43. Huang DM, Hsiao JK, Chen YC, Chien LY, Yao M, Chen YK, Ko BS, Hsu SC, Tai LA, Cheng HY, Wang SW, Yang CS, Chen YC. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials 2009; 30: 3645-3651.
44. Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 2008; 3: 703-717.
45. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nano-particles and transfection agent for cellular MR imaging. Radiology 2003; 229: 838-846. (Pubitemid 37467591)
46. Pawelczyk E, Arbab AS, Pandit S, Hu E, Frank JA. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed. 2006; 19: 581-592. (Pubitemid 44240784)
47. Rice HE, Hsu EW, Sheng H, Evenson D, Freemerman AJ, Safford KM, Provenzale JM, Warner DS, Johnson GA. Superparamagnetic iron oxide labeling and transplantation of adipose-derived stem cells in middle cerebral artery occlusion-injured mice. Am. J. Roentgenol. 2007; 188: 1101-1108.
48. Hu F, Neoh K, Cen L, Kang E. Cellular response to magnetic nanoparticles 'PEGylated' via surface-initiated atom transfer radical polymerization. Biomacromolecules 2006; 7: 809-816.
49. Pernodet N, Fang X, Sun Y, Bakhtina A, Ramakrishnan A, Sokolov J, Ulman A, Rafailovich M. Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2006; 2: 766-773. (Pubitemid 43745149)
50. Lipski AM, Pino CJ, Haselton FR, Chen IW, Shastri VP. The effect of silica nanoparticle-modified surfaces on cell morphology, cyto-skeletal organization and function. Biomaterials 2008; 29: 3836-3846.
51. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004; 17: 513-517. (Pubitemid 39549429)
52. Snyder EY, Yoon C, Flax JD, Macklis JD. Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc. Natl. Acad. Sci. USA 1997; 94: 11663-11668.
53. Pisanic TR 2nd, Blackwell JD, Shubayev VI, Fiñones RR, Jin S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007; 27: 2572-2581.
54. Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small 2008; 4: 26-49.
55. Hussain SM, Braydich-Stolle LK, Schrand AM, Murdock RC, Yu KO, Mattie DM, Schlager JJ, Terrones M. Toxicity evaluation for safe use of nanomaterials: recent achievements and technical challenges. Adv. Mater. 2009; 21: 1-11.
56. Maurer-Jones MA, Bantz KC, Love SA, Marquis BJ, Haynes CL. Toxicity of therapeutic nanoparticles. Nanomedicine 2009; 4: 219-241.
57. Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD. Cellular uptake and cytotoxicity of gold nanorods: Molecular origin of cytotoxicity and surface effects. Small 2009; 5: 701-708.
58. Yen HJ, Hsu SH, Tsai CL. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 2009; DOI: 10.1002/smll.200900126.
59. Thorek DL, Tsourkas A. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 2008; 29: 3583-3590.
60. Berry CC, Wells S, Charles S, Curtis AS. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003; 24: 4551-4557. (Pubitemid 37013615)
61. Reddy AM, Kwak BK, Shim HJ, Ahn C, Cho SH, Kim BJ, Jeong SY, Hwang SJ, Yuk SH. Functional characterization of mesenchymal stem cells labeled with a novel PVP-coated superparamagnetic iron oxide. Contrast Media Mol. Imag. 2009; 4: 118-126.
62. Lu F, Wu SH, Hung Y, Mou CY. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 2009; DOI: 10.1002/smll200900005.
63. Jiang W, Kim BY, Rutka JT, Chan WC. Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 2008; 3: 145-150.